(Q43939030)

28 November 2017

Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer (English)

1 reference

28 November 2017

phase II clinical trial

0 references

1 reference

1 reference

Aziz Z

1

1 reference

28 November 2017

Zahid M

series ordinal

2

1 reference

28 November 2017

Ud Din Ahmed Z

series ordinal

3

1 reference

28 November 2017

Arshad T

series ordinal

4

1 reference

28 November 2017

1 June 1998

1 reference

Australian and New Zealand journal of medicine

28 November 2017

1 reference

28 November 2017

28

1 reference

28 November 2017

403-409

1 reference

28 November 2017

3

1 reference

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma

28 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Ifosfamide and mesna in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Ovarian cancer, Part I: Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1998.TB01975.X

10.1111/J.1445-5994.1998.TB01975.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference